Extendicare Inc (EXE) - Net Assets
Based on the latest financial reports, Extendicare Inc (EXE) has net assets worth CA$373.37 Million CAD (≈ $270.09 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$1.07 Billion ≈ $771.50 Million USD) and total liabilities (CA$693.14 Million ≈ $501.41 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Extendicare Inc's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$373.37 Million |
| % of Total Assets | 35.01% |
| Annual Growth Rate | -2.08% |
| 5-Year Change | 266.33% |
| 10-Year Change | 113.65% |
| Growth Volatility | 58.46 |
Extendicare Inc - Net Assets Trend (1998–2025)
This chart illustrates how Extendicare Inc's net assets have evolved over time, based on quarterly financial data. Also explore EXE total assets for the complete picture of this company's asset base.
Annual Net Assets for Extendicare Inc (1998–2025)
The table below shows the annual net assets of Extendicare Inc from 1998 to 2025. For live valuation and market cap data, see how much is Extendicare Inc worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CA$373.37 Million ≈ $270.09 Million |
+200.25% |
| 2024-12-31 | CA$124.35 Million ≈ $89.95 Million |
+41.44% |
| 2023-12-31 | CA$87.92 Million ≈ $63.60 Million |
-12.69% |
| 2022-12-31 | CA$100.70 Million ≈ $72.85 Million |
-1.20% |
| 2021-12-31 | CA$101.92 Million ≈ $73.73 Million |
-20.49% |
| 2020-12-31 | CA$128.19 Million ≈ $92.73 Million |
+11.07% |
| 2019-12-31 | CA$115.41 Million ≈ $83.49 Million |
-8.40% |
| 2018-12-31 | CA$125.99 Million ≈ $91.14 Million |
-2.30% |
| 2017-12-31 | CA$128.96 Million ≈ $93.28 Million |
-26.21% |
| 2016-12-31 | CA$174.76 Million ≈ $126.42 Million |
+1.53% |
| 2015-12-31 | CA$172.13 Million ≈ $124.52 Million |
+6974.16% |
| 2014-12-31 | CA$-2.50 Million ≈ $-1.81 Million |
-106.70% |
| 2013-12-31 | CA$37.38 Million ≈ $27.04 Million |
-31.62% |
| 2012-12-31 | CA$54.66 Million ≈ $39.54 Million |
+13.12% |
| 2011-12-31 | CA$48.32 Million ≈ $34.95 Million |
-84.68% |
| 2010-12-31 | CA$315.31 Million ≈ $228.09 Million |
+870.87% |
| 2009-12-31 | CA$-40.90 Million ≈ $-29.59 Million |
-38.50% |
| 2008-12-31 | CA$-29.53 Million ≈ $-21.36 Million |
-25.25% |
| 2007-12-31 | CA$-23.58 Million ≈ $-17.06 Million |
+0.32% |
| 2006-12-31 | CA$-23.65 Million ≈ $-17.11 Million |
-104.86% |
| 2005-12-31 | CA$486.54 Million ≈ $351.95 Million |
+6.47% |
| 2004-12-31 | CA$456.99 Million ≈ $330.58 Million |
+28.21% |
| 2003-12-31 | CA$356.43 Million ≈ $257.84 Million |
+0.73% |
| 2002-12-31 | CA$353.83 Million ≈ $255.96 Million |
+0.90% |
| 2001-12-31 | CA$350.70 Million ≈ $253.69 Million |
-8.20% |
| 2000-12-31 | CA$382.02 Million ≈ $276.35 Million |
-12.66% |
| 1999-12-31 | CA$437.38 Million ≈ $316.39 Million |
-33.59% |
| 1998-12-31 | CA$658.62 Million ≈ $476.44 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Extendicare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 29967600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CA$662.85 Million | 177.53% |
| Other Comprehensive Income | CA$-6.09 Million | -1.63% |
| Other Components | CA$16.29 Million | 4.36% |
| Total Equity | CA$373.37 Million | 100.00% |
Extendicare Inc Competitors by Market Cap
The table below lists competitors of Extendicare Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AF Gruppen ASA
OL:AFG
|
$2.06 Billion |
|
SF Diamond
SHE:300179
|
$2.07 Billion |
|
Guangdong No2 Hydropower Engineering Co Ltd
SHE:002060
|
$2.07 Billion |
|
Bestway Marine & Energy Technology Co Ltd
SHE:300008
|
$2.07 Billion |
|
Maxvision Technology Corp
SHE:002990
|
$2.06 Billion |
|
MLS Co Ltd
SHE:002745
|
$2.06 Billion |
|
Allied Machinery Co. Ltd.
SHG:605060
|
$2.06 Billion |
|
Mirgor S.A.
BA:MIRG
|
$2.06 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Extendicare Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 124,352,000 to 373,370,000, a change of 249,018,000 (200.3%).
- Net income of 96,656,000 contributed positively to equity growth.
- Dividend payments of 41,699,000 reduced retained earnings.
- New share issuances of 191,524,000 increased equity.
- Other comprehensive income increased equity by 667,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$96.66 Million | +25.89% |
| Dividends Paid | CA$41.70 Million | -11.17% |
| Share Issuances | CA$191.52 Million | +51.3% |
| Other Comprehensive Income | CA$667.00K | +0.18% |
| Other Changes | CA$1.87 Million | +0.5% |
| Total Change | CA$- | 200.25% |
Book Value vs Market Value Analysis
This analysis compares Extendicare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.02x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 3.53x to 7.02x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | CA$8.55 | CA$30.19 | x |
| 1999-12-31 | CA$5.84 | CA$30.19 | x |
| 2000-12-31 | CA$5.21 | CA$30.19 | x |
| 2001-12-31 | CA$5.01 | CA$30.19 | x |
| 2002-12-31 | CA$4.92 | CA$30.19 | x |
| 2003-12-31 | CA$5.05 | CA$30.19 | x |
| 2004-12-31 | CA$6.58 | CA$30.19 | x |
| 2005-12-31 | CA$7.13 | CA$30.19 | x |
| 2006-12-31 | CA$-0.34 | CA$30.19 | x |
| 2007-12-31 | CA$-0.34 | CA$30.19 | x |
| 2008-12-31 | CA$-0.41 | CA$30.19 | x |
| 2009-12-31 | CA$-0.47 | CA$30.19 | x |
| 2010-12-31 | CA$1.36 | CA$30.19 | x |
| 2011-12-31 | CA$0.57 | CA$30.19 | x |
| 2012-12-31 | CA$0.54 | CA$30.19 | x |
| 2013-12-31 | CA$0.43 | CA$30.19 | x |
| 2014-12-31 | CA$-0.03 | CA$30.19 | x |
| 2015-12-31 | CA$1.74 | CA$30.19 | x |
| 2016-12-31 | CA$1.75 | CA$30.19 | x |
| 2017-12-31 | CA$1.29 | CA$30.19 | x |
| 2018-12-31 | CA$1.28 | CA$30.19 | x |
| 2019-12-31 | CA$1.29 | CA$30.19 | x |
| 2020-12-31 | CA$1.43 | CA$30.19 | x |
| 2021-12-31 | CA$1.01 | CA$30.19 | x |
| 2022-12-31 | CA$1.13 | CA$30.19 | x |
| 2023-12-31 | CA$1.03 | CA$30.19 | x |
| 2024-12-31 | CA$1.30 | CA$30.19 | x |
| 2025-12-31 | CA$4.30 | CA$30.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Extendicare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 25.89%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.82%
- • Asset Turnover: 1.56x
- • Equity Multiplier: 2.86x
- Recent ROE (25.89%) is above the historical average (20.78%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 9.95% | 3.09% | 0.95x | 3.38x | CA$-353.30K |
| 1999 | -36.63% | -8.44% | 1.03x | 4.21x | CA$-203.30 Million |
| 2000 | -15.54% | -3.28% | 1.04x | 4.55x | CA$-97.42 Million |
| 2001 | -10.38% | -2.14% | 0.98x | 4.96x | CA$-71.48 Million |
| 2002 | 5.29% | 1.08% | 0.97x | 5.04x | CA$-16.87 Million |
| 2003 | 17.02% | 3.63% | 1.05x | 4.47x | CA$25.03 Million |
| 2004 | 27.20% | 7.12% | 1.22x | 3.12x | CA$78.59 Million |
| 2005 | 18.94% | 4.78% | 1.16x | 3.42x | CA$44.46 Million |
| 2006 | 0.00% | -2.05% | 1.33x | 0.00x | CA$-33.36 Million |
| 2007 | 0.00% | 3.99% | 1.22x | 0.00x | CA$72.74 Million |
| 2008 | 0.00% | 0.65% | 1.14x | 0.00x | CA$16.34 Million |
| 2009 | 0.00% | 3.59% | 1.30x | 0.00x | CA$81.80 Million |
| 2010 | 45.74% | 2.50% | 1.04x | 17.65x | CA$40.39 Million |
| 2011 | -62.91% | -1.45% | 1.14x | 37.89x | CA$-35.23 Million |
| 2012 | 114.63% | 3.08% | 1.13x | 33.08x | CA$57.19 Million |
| 2013 | 14.13% | 0.67% | 0.42x | 49.47x | CA$1.55 Million |
| 2014 | 0.00% | -2.30% | 0.43x | 0.00x | CA$-18.50 Million |
| 2015 | 134.83% | 24.60% | 0.92x | 5.97x | CA$214.87 Million |
| 2016 | 20.29% | 3.34% | 1.07x | 5.66x | CA$17.98 Million |
| 2017 | 1.65% | 0.19% | 1.17x | 7.24x | CA$-10.76 Million |
| 2018 | 25.19% | 2.83% | 1.25x | 7.11x | CA$19.14 Million |
| 2019 | 24.81% | 2.53% | 1.27x | 7.70x | CA$17.09 Million |
| 2020 | 42.27% | 4.91% | 1.15x | 7.51x | CA$41.37 Million |
| 2021 | 11.29% | 0.99% | 1.30x | 8.83x | CA$1.31 Million |
| 2022 | 69.07% | 5.69% | 1.56x | 7.76x | CA$59.48 Million |
| 2023 | 38.65% | 2.60% | 1.94x | 7.65x | CA$25.19 Million |
| 2024 | 60.48% | 5.13% | 2.04x | 5.79x | CA$62.77 Million |
| 2025 | 25.89% | 5.82% | 1.56x | 2.86x | CA$59.32 Million |
Industry Comparison
This section compares Extendicare Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $227,568,710
- Average return on equity (ROE) among peers: -18.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Extendicare Inc (EXE) | CA$373.37 Million | 9.95% | 1.86x | $2.06 Billion |
| HealWELL AI Inc. (AIDX) | $123.94 Million | -37.87% | 1.30x | $201.58 Million |
| CareRx Corp (CRRX) | $-19.96 Million | 0.00% | 0.00x | $167.61 Million |
| dentalcorp Holdings Ltd (DNTL) | $1.79 Billion | -0.93% | 0.89x | $1.52 Billion |
| Medical Facilities Corporation (DR) | $114.69 Million | -3.84% | 2.29x | $218.65 Million |
| Element Lifestyle Retirement Inc (ELM) | $-590.09K | 0.00% | 0.00x | $509.83K |
| Jack Nathan Medical Corp (JNH) | $8.52 Million | -116.33% | 0.25x | $68.71 |
| KDA Group Inc (KDA) | $-3.65 Million | 0.00% | 0.00x | $16.18 Million |
| Nova Leap Health Corp (NLH) | $9.84 Million | 12.76% | 0.78x | $24.32 Million |
| NeuPath Health Inc (NPTH) | $27.62 Million | -18.31% | 0.67x | $22.40 Million |
About Extendicare Inc
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occup… Read more